26 results
Thumbnail

D2. 259 - A Comprehensive Decision Algorithm for Hypersensitivity Reactions to Iodinated Contrast Media in a Tertiary Care Setting

Thumbnail

D2.255 - NSAID Hypersensitivity Records: Assessing Documentation Practice, Challenges, and Areas for Improvement

Thumbnail

D2.256 - Cytokine release reaction after subcutaneous daratumumab

Thumbnail

D2.246 - Anaphylaxis to sugammadex in a 15 year-old-girl

Thumbnail

D2.247 - Sensitization to Meloxicam, Celecoxib and Paracetamol in patients intolerant to non-steroidal antiinflamatory drugs (NSAIDS)

Thumbnail

D2.248 - Allergy to quinolones: a clinical case

Thumbnail

D2.249 - Application of Desensitization Protocol with Rituximab in the Treatment of Corticosteroid-Dependent Nephrotic Syndrome in an Adolescent

Thumbnail

D2.250 - Can drug allergy develop in x-linked agammaglobulinemia (xla)? case report

Thumbnail

D2.251 - Anaphylaxis due to Andrographis panniculata - an emerging problem

Thumbnail

D2.252 - Confirmation of selectivity pattern to Non-Steroidal Anti-inflammatory Drugs: a retrospective study in a Central Hospital

Thumbnail

D2.253 - Is it possible to treat DRESS without systemic corticosteroids?

Thumbnail

D2.254 - Can a medication leave its mark on the skin?

Thumbnail

D2.257 - Anaphylaxis with FOLFOX scheme: not everything is Oxaliplatin

Thumbnail

D2.258 - Fixed drug eruption caused by co-amoxiclav

Thumbnail

D2.351 - Relapse Rate and Risk Factors After Omalizumab Treatment in Adolescents with Chronic Spontaneous Urticaria

Thumbnail

D2.352 - Assessing Risk Factors for Relapse Following Omalizumab Discontinuation in Chronic Urticaria

Thumbnail

D2.353 - A Single Dose of Briquilimab, An Anti-Human CD117 (c-Kit) Antibody, Protects Against Relapse of Epicutaneous Allergen-Induced Dermatitis in Mice Expressing Chimeric Human/Mouse CD117

Thumbnail

D2.354 - Questionnaire survey of new treatments for atopic dermatitis

Thumbnail

D2.355 - Concurrent use of dupilumab and omalizumab in severe atopic dermatitis and severe chronic urticaria

Thumbnail

D2.356 - Real-life effectiveness of omalizumab and its impact on quality of life in patients with chronic spontaneous urticaria